The growth of the global Crohn’s disease treatment market can be attributed majorly to the increasing number of patients hospitalized, followed by the rise in new Crohn’s diseases, and recurring cases. For instance, nearly 100 hospitals there are more than 15 hospital re-admission of people aged above 65 within the 30 days from the discharge for Crohn’s diseases in the United States every year. On the other hand, the surging number of surgeries in order to deal with Crohn’s diseases. Nearly one in five people dealing with Crohn’s disease needs major surgery in the first five years after the diagnosis in the United Kingdom.
The global Crohn’s disease treatment market is also estimated to grow majorly on account of the following:
- Risk of Crohn’s disease in people who smoke
Lack of familiarity with the different treatment options for Crohn’s disease and the difficulty in diagnosing Crohn’s disease as a result of its similarity of symptoms with other disorders are expected to affect the market adversely. Further, the treatment for the IBDs involves high expense, with only the initial year spending after diagnosis coming up to USD 26,556. Hence, this factor is expected to be the major hindrance for the growth of the global Crohn’s disease treatment market during the forecast period.
Know More About the Complete Study @ https://www.researchnester.com/reports/crohns-disease-treatment-market/3004
Global Crohn's Disease Treatment Market Segmentation
- By Treatment (Non-Surgical, and Surgical)
Between these, the non-surgical treatment segment is expected to hold the largest market share by the end of 2035 as a result of the relatively high-efficiency rate of non-surgical medications in treating the symptoms of Crohn’s disease. For instance, as per a study conducted by the National Center for Biotechnology Information (NCBI), the initiation of the immune-system suppressant methotrexate in patients with active Crohn’s disease results in clinical remission in 72% of patients after just 3 months.
- By End User (Research Institutes, Hospitals and Clinics, and Others)
- By Type (Granulomatous colitis, Ileocolitis, Ileitis, Gastroduodenal Crohn’s Disease, Jejunoileitis, and Perianal Crohn’s Disease)
- By Region
The Asia Pacific Crohn’s disease treatment market is expected to hold the largest market, among the market in all the other regions share, by the end of 2035. The regional market is anticipated to grow as a result of the growing prevalence of IBDs in the Asia-Pacific region, general awareness of the disease, and the many opportunities for treatment innovations there. The frequency of IBDs in East Asia alone is projected to grow from ~3 million cases in 2020 to ~5 million cases in 2035.
The market research report on global Crohn’s disease treatment also includes the market size, market revenue, Y-o-Y growth, and key player analysis applicable for the market in North America (U.S., and Canada), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), and Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa).
Key Market Players Featured in the Global Crohn's Disease Treatment Market
Some of the key players of the global Crohn’s disease treatment market are Tiziana Life Sciences pls, AbbVie Inc., Johnson & Johnson Services Inc., Pfizer Inc., Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, UCB S.A., Ferring B.V., Bristol-Myers Squibb Company
About Research Nester
Research Nester, which is a leading service provider for strategic market research and consulting services, aims to provide unbiased, unparalleled market insights and industry analysis. These analyses help conglomerates, executives, and industries to take wise decisions for their businesses as well as for their future marketing strategy, expansion and investment among others. We believe that our expertise in the field of market research can help businesses to expand to its new horizon. Our team of research analysts can provide businesses a right guidance at the right time, while our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
